Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20474961

Stopping a trial early in oncology : for patients or for industry?

Author
TROTTA, F1 ; APOLONE, G2 ; GARATTINI, S2 ; TAFURI, G1 3
[1] Italian Medicines Agency (AIFA), Rome, Italy
[2] Mario Negri Institute for Pharmacological Research, Milan, Italy
[3] Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands
Source

Annals of oncology. 2008, Vol 19, Num 7, pp 1347-1353, 7 p ; ref : 35 ref

ISSN
0923-7534
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
EMEA FDA RCT anticancer drugs end point interim analysis
Keyword (fr)
Anticancéreux Cancérologie Essai clinique Homme Industrie Médicament Précoce Tumeur maligne Analyse intermédiaire Cancer
Keyword (en)
Antineoplastic agent Cancerology Clinical trial Human Industry Drug Early Malignant tumor Interim analysis Cancer
Keyword (es)
Anticanceroso Cancerología Ensayo clínico Hombre Industria Medicamento Precoz Tumor maligno Cáncer
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20474961

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web